Dr. Scott Bralow, DO (he/him) is a Nephrologist in Bala Cynwyd, PA with over 18 years of experience. What is your opinion of Dr. Scott Bralow, DO? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Scott Bralow, DO has received over $2,071 which includes payments from the following companies:
$360.87 from Amgen Inc.
$343.87 from AstraZeneca Pharmaceuticals LP
$213.25 from Keryx Biopharmaceuticals, Inc.
$180.39 from Otsuka America Pharmaceutical, Inc.
$176.87 from Teva Pharmaceuticals USA, Inc.
$124.58 from Merck Sharp & Dohme Corporation
$84.60 from GlaxoSmithKline, LLC.
$66.74 from Boehringer Ingelheim Pharmaceuticals, Inc.
$58.84 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
$45.74 from LILLY USA, LLC
$45.65 from Takeda Pharmaceuticals America, Inc.
$42.55 from Allergan Inc.
$37.63 from Amarin Pharma Inc.
$36.69 from Valeant Pharmaceuticals North America LLC
$33.07 from Astellas Pharma US Inc
$30.39 from sanofi-aventis U.S. LLC
$22.45 from OPTOS, INC.
$19.52 from Novartis Pharmaceuticals Corporation
$19.38 from Fresenius USA Marketing, Inc.
$19.30 from Concordia Pharmaceuticals Inc.
Payments received by Dr. Scott Bralow, DO were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!